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Edited by Roberto SitiaAbstract Proteins synthesized in the endoplasmic reticulum
(ER) lumen are exposed to several dedicated chaperones and
folding factors that ensure eﬃcient maturation. Nevertheless,
protein folding remains error-prone and mutations in the poly-
peptide sequence may signiﬁcantly reduce folding-eﬃciency.
Folding-incompetent proteins carrying N-glycans are extracted
from futile folding cycles in the calnexin chaperone system upon
intervention of EDEM1, EDEM2 and EDEM3, three ER-stress-
induced members of the glycosyl hydrolase 47 family. This re-
view describes current knowledge about mechanisms regulating
folding and disposal of glycoproteins.
 2007 Federation of European Biochemical Societies. Pub-
lished by Elsevier B.V. All rights reserved.
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EDEM31. Introduction
Each protein is composed of a speciﬁc amino acid sequence
that, to become biologically active and to be transported at the
appropriate intra- or extracellular destination, must fold into a
deﬁned three-dimensional structure, usually the most thermo-
dynamically stable. N-glycosylation, the co-translocational
addition of pre-assembled core glycans to nascent polypeptide
chains emerging in the ER lumen, facilitates the folding pro-
cess by recruiting members of the calnexin (Cnx) chaperone
system. This is an ensemble of sugar (glucose)-binding lectins,
sugar (glucose)-modifying enzymes and dedicated oxidoreduc-
tases that retains newly synthesized proteins in a folding-
friendly environment and assists rate-limiting steps of the
folding process. Acquisition of the protein’s native structure
may fail or may progress unacceptably slowly, as in the case
of mutations in the amino acid sequence. Activation of a dis-
posal machinery that removes folding-defective and terminally
misfolded products from the folding compartment and trans-
port them across the ER membrane into the cytosol for prote-
asomal degradation is crucial in these cases to maintain cell
and organism homeostasis [1]. The ER disposal machinery
comprises sugar (mannose)-binding lectins and sugar (man-
nose)-modifying enzymes and takes advantage of the N-gly-*Corresponding author. Fax: +41 0 918200302.
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interrupt futile folding attempts and to initiate the degradation
program [2,3]. A detailed comprehension of the mechanisms of
protein folding and protein degradation in the ER is of crucial
importance because several human diseases are characterized
by mutations in the polypeptide sequence that severely impairs
the folding process. If the defective polypeptide chain
undergoes aggregation, the disease is characterized by a
gain-of-toxic function phenotype (e.g. liver disease in the a1-
antitrypsin deﬁciency); if, on the other hand, the defective
polypeptide is rapidly degraded, the disease is characterized
by a loss-of-function phenotype (e.g. cystic ﬁbrosis) [4].2. Glycoprotein folding and ER quality control
2.1. Chaperone-assisted protein folding in the ER
The ER is the site of synthesis and folding of secretory pro-
teins and of proteins operating at the plasma membrane or in
intracellular compartments such as the ER, the endosomes, the
lysosomes and the Golgi [1]. Formation of disulﬁde bonds and
addition of pre-assembled core glycans composed of three glu-
cose (Glc), nine mannose (Man) and two N-acetylglucosamine
(GlcNAc) residues (Fig. 1A) are peculiar co- and post-transla-
tional modiﬁcation of proteins synthesized in the ER.
The addition of core glycans (N-glycosylation) by the oli-
gosaccharyl transferase (OST) occurs co-translationally as
soon as a conserved Asn-Xxx-Ser/Thr consensus amino acid se-
quence enters the ER lumen (Fig. 2, step 1) [5]. N-glycosylation
increases the overall solubility of as yet unstructured newly
synthesized chains, recruits chaperones and folding factors
dedicated to assistance of glycosylated chains, serves as a
hydrophilic appendix that signals when the time allocated to
complete the folding program has expired (see below). Termi-
nal glucoses are rapidly removed by ER-localized a-glucosi-
dases to form the Glc1Man9GlcNAc2 sugar composition. In
particular, the sequential removal of the two outermost glucose
residues belonging to the N-glycan’s branch A is mediated by
the glucosidase I (GI) and the glucosidase II (GII) (Fig. 2, step
2) [5]. GI removes the ﬁrst glucose as soon as the N-glycan has
been transferred on the nascent polypeptide chain. Recent data
have demonstrated that GII, composed by the catalytic subunit
a and by the mannose 6-phosphate receptor like domain b, can
cleave the second glucose only if its b domain interacts with
another N-glycan (transactivation) [6]. The trimming of the
glucose in position two is therefore slower but may occur
before the synthesis of the polypeptide chain is completed.blished by Elsevier B.V. All rights reserved.
Fig. 1. N-glycan composition. (A) The precursor oligosaccharide added to the nascent polypeptide is composed of two N-acetylglucosamine (black
squares), nine mannose (yellow and red circles) and three glucose residues (blue triangles). Mannose residues linked with an a1,2 bond are shown as
red circles. The three N-glycan branches are labelled as A, B and C and the three glucose residues are labelled as 1, 2 and 3. Mannoses removal is
necessary to generate the sweet degradation tag indicated in (B). (C) The precursor oligosaccharide added to the nascent polypeptide in the B3F7 cells
is composed of only four mannose residues. (D) the putative degradation signal of misfolded glycoproteins synthesized in B3F7 cells. Kifunensine
(Kif) and deoxymannojirimycin (dMNJ) inhibit mannose removal and ERAD.
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entry of the nascent chain in the glycoprotein-dedicated Cnx/
calreticulin (Crt)-ERp57 chaperone system [5] (Fig. 2, step 2).
Cnx, a membrane-bound protein, and Crt, its soluble homo-
log, are monomeric, calcium-binding, ER-resident chaperones
that contain a sugar binding domain and a proline rich P-do-
main. Cnx and Crt have the identical carbohydrate speciﬁcity
for mono-glucosylated trimming intermediates of polypeptide-
bound oligosaccharides but associate with distinct substrate
populations [3]. In addition to the glucose 3 at least three man-
nose residues of the branch A (Fig. 1A) critically contribute to
substrate association with Cnx/Crt. The binding-aﬃnity is low
(lM to mM) and the interaction is transient. Whether Cnx or
Crt can interact directly with the polypeptide chain is matter of
ongoing investigation [7].
The P-domain of Cnx and Crt mediates the interaction with
ERp57 [8,9], a member of the protein disulﬁde isomerase (PDI)
superfamily. Association with Cnx/Crt makes of ERp57 the
glycoprotein-dedicated oxidoreductase. Disulﬁde bonds are
important for the stability of the native protein structure,
and the mispairing of cysteine residues can prevent proteins
from attaining the native conformation. Oxidative folding con-
sists in a co-translational phase during which nascent chain
cysteines are oxidized to form intra-molecular disulﬁdes and
in a post-translational phase, where disulﬁdes are rearranged
into the native set. Studies of the oxidative folding of inﬂuenza
virus hemagglutinin (HA) revealed that ERp57 plays a crucial
role in the isomerization of non-native disulﬁde bonds occur-ring during the post-translational phases of the HA folding
program [10].
Thus, entry in the Cnx chaperone system protects nascent
chains from aggregation and facilitates the polypeptide folding
process by recruiting the dedicated oxidoreductase ERp57.
The initial stage in the folding of the glycoproteins is con-
served in S. cerevisiae where Cne1p has been identiﬁed as the
functional ortholog of Cnx [11] (a Crt ortholog has not been
identiﬁed). The yeast Cne1p has a short cytosolic domain, a lec-
tin domain that mediates association with mono-glucosylated
substrates and a conserved P-domain that mediates the interac-
tion withMpd1p, a putative ERp57 ortholog [12]. Cne1p, as ex-
pected, works as a chaperone in the yeast ER and enhance
folding eﬃciency of newly synthesized proteins [11]. The major
diﬀerence between glycoprotein folding between S. cerevisiae
and mammalian cells is the lack of a functional ortholog of
the mammalian quality control sensor UDP-glucose:glycopro-
tein glucosyltransferase (UGT1, see below).
2.2. Cnx, Crt and ERp57 knock out mice and cell lines
To better understand the mechanism of glycoprotein fold-
ing, knock out mice that either lack Cnx [13] or Crt [14] or
ERp57 [10,15] have been generated. The Cnx knock out mice
show growth defects and motor disorders resulting in prema-
ture death. The Crt and ERp57 knock out mice die in uterus.
Thus, even though the folding machinery appears to be highly
redundant with several chaperones and folding factors display-
ing similar substrate speciﬁcities and/or enzymatic activities
Fig. 2. Folding, quality control and ER-associated degradation. The core oligosaccharide is co-translationally added to the nascent polypeptide by
the OST (1). Glucose residues are indicated as ‘‘G’’ and mannose residues as circles (a1,2-linked mannoses are in red). The two outermost glucoses
are removed sequentially by the GI (fast) and by the GII (regulated) (2). Cnx/Crt bind the mono-glucosylated N-glycan thus exposing the newly
synthesized glycoprotein to ERp57. Native proteins: Once released by the chaperone complex, the outermost glucose is removed by the GII (5).
Native proteins are released from the ER and transported at the appropriate destination (6). Folding intermediates or terminally misfolded
glycoproteins: Folding intermediates are released by the Cnx/Crt-ERp57 complex (3a) and the outermost glucose is removed by the glucosidase II
(5a). UGT1 reglucosylates glycoproteins with ’’pseudo-native structure’’ (7) resulting in a second round of association with Cnx/Crt/ERp57 (4a).
Terminally misfolded polypeptides become substrates of ER-resident members of the GH47 family, such as ER a1,2 mannosidase I and EDEMs (8).
Misfolded proteins might be retained in the ER by the formation of size regulated aggregates containing BiP (9) or by interacting with EDEM1 that
prevents aggregates formation (10). Non-native polypeptides are eventually retro-translocated into the cytosol for proteasomal degradation (11).
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bers of the PDI superfamily), individual deletions may have se-
vere phenotypes possibly related to speciﬁc requirement of the
deleted protein during embryogenesis or in the function of spe-
ciﬁc organs.
Analysis of several model glycoproteins in cell lines derived
from embryos lacking individual ER-resident factors shed light
on mechanisms regulating glycoprotein folding and quality
control in the mammalian ER. The knock out cells showed
similar viability, proliferation rate, morphology and stress lev-
els compared to wild type cells. However, select folding sub-
strates suﬀered of characteristic maturation defects upon
depletion of individual chaperones. For instance, inﬂuenza
virus HA proved dependent on Cnx [16,17] and the MHC class
I heavy chain on Crt [18] for eﬃcient maturation and transport
at the plasma membrane. Maturation of HA [10], of class I [15]
and of several proteins lacking deﬁned secondary structures
and bearing a large number of disulﬁde bonds also rely on
ERp57 [19]. Thus, although normally exploited by a plethora
of gene products synthesized in the mammalian ER, the
Cnx/Crt-ERp57 system seems to be strictly required for a re-
stricted fraction of polypeptides only.
Besides general chaperones and folding enzymes the ER also
contains several substrate-dedicated chaperones (e.g. the colla-
gen-speciﬁc Hsp47) and the LDL receptor speciﬁc RAP (thor-
oughly reviewed in [1]).
2.3. Protein quality control in the ER lumen
Immediately after substrate release from Cnx/Crt (Fig. 2,
step 3), the GII removes the innermost glucose of the N-gly-can’s branch A (Fig. 2, step 5). This inhibits re-association
of the glycoprotein with the glucose-binding lectins (Fig. 2,
step 4). The structure of the free glycopolypeptide is checked
by the UGT1. UGT1 ignores native polypeptides that can
leave the ER through the secretory line (Fig. 2, step 6). It also
ignores terminally misfolded proteins that are deviated into the
disposal machinery and prepared for retro-translocation into
the cytosol and proteasome-mediated degradation (Fig. 2, step
8) [3]. UGT1 selectively re-glucosylates the mannose on branch
A of polypeptides with nearly native conformation (Fig. 2, step
7) [20] thereby causing their re-association with calnexin/calret-
iculin-ERp57 for further folding attempts (Fig. 2, step 4a).
It is not fully understood how UGT1 can distinguish native
and non-native structures, but it is reasonable to think that this
depends on the presence of exposed hydrophobic residues, mo-
bile loops, non-native determinants or the lack of compact-
ness. Also, diﬀerent models have been proposed on the
requirements for N-glycans re-glucosylation. A ﬁrst model
claims that re-glucosylation only occurs if the N-glycan is adja-
cent to the structural defect in the polypeptide chain [21,22], a
second model claims that N-glycans are re-glucosylated inde-
pendent on structural-defect’s proximity [23].
2.4. UGT1 knock out mouse and cell lines
Deletion of UGT1 is embryonic lethal in mice, with only few
mice surviving until birth [24]. Generation of embryonic ﬁbro-
blasts allowed, however, some studies on mechanisms regulat-
ing protein quality control in the mammalian ER. It has been
reported that association with Cnx/Crt and UGT1 activity
are dispensable for retention in the ER of folding-defective
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folding-incompetent glycoproteins with Cnx, terminally mis-
folded polypeptides are in fact eventually handed oﬀ from
Cnx to BiP (Fig. 2, step 9), a member of the heat shock 70 pro-
tein family. UGT1 oﬀers to folding-defective glycopolypep-
tides additional chances to correct their structure, but it is
association with BiP of the substrates escaping the Cnx chap-
erone system that ensures tightness of ER quality control,
independent on presence/absence of UGT1 [24].
Lack of substantial ER stress upon UGT1-deletion shows
that, at least in cultured cells, most of the cellular proteins
may acquire a transport-competent structure in a single bind-
ing-event with Cnx/Crt-ERp57 [24], as it is also the case for
proteins synthesized in S. pombe where the UGT1 ortholog
is present but dispensable for viability under normal condi-
tions [25].3. Degradation of folding-incompetent proteins from the ER
At the beginning of the 1990s the degradation of misfolded
proteins synthesized in the ER lumen was thought to occur
in the ER lumen and to be operated by ER-resident proteases
[26]. It was consequently named ‘‘ER degradation’’. In the mid
1990s, the concept of ‘‘ER-associated degradation’’ replaced
the ‘‘ER degradation’’ model as cumulating data showed that
misfolded proteins synthesized in the ER were retro-translo-
cated into the cytosol and degraded by the 26S proteasome
[27,28]. Since then, the mechanisms regulating ERAD have
been thoroughly studied, in particular those regulating dis-
posal from the ER of folding-defective proteins carrying
N-linked oligosaccharides.
3.1. Mannose trimming. . .the signal for destruction
Data showing that removal of a1,2-bonded mannose resi-
dues from N-glycans displayed on misfolded polypeptides
was required for their disposal from the ER [29] were pub-
lished even before data showing that the 26S proteasome was
the proteolytic machinery operating degradation (reviewed in
[30]). For most if not all glycosylated ERAD substrates, sugar
analogs such as kifunensine or deoxymannojirimycin-deriva-Fig. 3. Schematic representation of GH47 family members. The GH47 fa
mannosidase I, a collection of Golgi a1,2 mannosidases (GolgiManIA, IB and
conserved mannosidase homology domain is in violet. There is little or no
contains a protease-associated domain (PA) and the KDEL retention signa
GolgiManIA, IB and IC is shown in dark blue. The putative transmembrantives are as eﬃcient as proteasomal drugs in inhibiting protein
degradation from the ER [31]. Kifunensine and deoxymannoj-
irimycin-derivatives are cell permeable compounds that selec-
tively target ER and Golgi-resident members of the glycosyl
hydrolase 47 (GH47) family comprising the ER a1,2 mannos-
idase I, the Golgi a1,2 mannosidases IA, IB and IC and the
three ER-resident proteins EDEM1, EDEM2, EDEM3
(Fig. 3). Which of these is (are) involved, and how, in glyco-
protein disposal from the ER is matter of intensive study.
Genetic evidence in S. cerevisiae shows a clear involvement
of Mns1p [32] and of Htm1p [33], the ER a1,2 mannosidase
I and EDEM1 orthologs, respectively. Mns1p speciﬁcally re-
moves from N-glycans of folding-defective polypeptides the
outermost mannose of branch B generating a strong signal
for disposal. Htm1p would then act as a mannose8-binding lec-
tin [33], even though results are controversial as other studies
report that Mns1p activity upon the ERAD substrates (thus,
substrate de-mannosylation) is not required for Htm1p inter-
vention [34]. The speciﬁcity of Mns1p for mannose B
(Fig. 1A) is conserved in the mammalian ortholog. The ER
a1,2 mannosidase I can, however, also remove other a1,2-
bonded terminal mannoses at rather unphysiological condi-
tions such as high concentrations and prolonged incubations
in vitro [35].
In the mammalian ER the situation is much more complex
and, importantly, removal of a single mannose residue does
not seem to be suﬃcient to elicit disposal from the ER of mis-
folded glycopolypeptides [2,36]. The main diﬀerence between
mammalian and yeast mechanisms regulating protein biogene-
sis/disposal is that S. cerevisiae lacks a functional UGT1
homolog. Hence, substrate release from the yeast Cnx chaper-
one system is virtually irreversible and polypeptides can di-
rectly be deviated in the disposal machinery. On the
contrary, folding-defective glycopolypeptides can be retained
in the mammalian Cnx system as long as they display N-gly-
cans with a re-glucosylatable mannose A (Fig. 1A). Consis-
tently, cumulating data support a model in which extensive
substrate de-mannosylation to mannose56 structures lacking
mannose A is required for protein degradation from the mam-
malian ER (Fig. 2, steps 8–10) [37–40]. The most compelling
are probably those showing that mannose removal remainsmily comprises three subfamilies of proteins including the ER a1,2
IC) and three EDEM proteins (EDEM1, EDEM2 and EDEM3). The
conservation among family members beyond this domain. EDEM3
l. The transmembrane regions of the ER a1,2 mannosidase I, and of
e region of EDEM1 is indicated in light blue.
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chol-deﬁcient cell lines (e.g. B3F7 [41] and MadIA214 [42]
(Fig. 1C)) characterized by addition of aberrant oligosaccha-
rides on nascent chains where the only cleavable a1,2-bonded
mannoses are those on branch A [43,44].3.2. Members of the GH47 family involved in the extensive de-
mannosylation of ERAD candidates in the mammalian ER
The GH47 family members (Golgi a1,2 mannosidases IA, IB
and IC, ER a1,2 mannosidase I and EDEM1, EDEM2,
EDEM3) have been implicated in disposal of misfolded glyco-
proteins from the ER lumen based on the genetic data in
S. cerevisiae and/or because their speciﬁc inhibitors deoxyman-
nojirimycin and kifunensine are potent ERAD inhibitors (see
above).
Golgi members of the GH47 family catalyze mannoses re-
moval from branches A and C and, with much lower eﬃciency,
from branch B [45]. Their intervention in glycoprotein disposal
from the ER would require traﬃc of ERAD candidates in the
Golgi compartment (which has not been shown in mammalian
cells) or residence of a sub-fraction of these enzymes in the ER.
An intervention of the ER a1,2 mannosidase I is more likely,
even though kinetic studies have shown that extensive N-gly-
can processing beyond removal of the mannose B requires high
enzyme concentrations or prolonged incubations [35] that can
only be envisioned if this mannosidase would be sequestered in
highest amounts in a specialized sub-compartment of the ER.
Another model claims that members of the third subfamily
of GH47 enzymes comprising EDEM1, EDEM2, and EDEM3
are directly, or indirectly involved in substrate de-mannosyla-
tion. Consistently, recent data indicate that the overexpression
of EDEM1 and EDEM3 enhances mannose removal from
misfolded glycoproteins (Fig. 2, step 8) [44,46].3.3. The EDEM proteins
The mouse EDEM1 gene is transcribed into two mRNA spe-
cies of 2.4 and 6 kb originating from diﬀerent polyadenylation
sites [47]. EDEM2 and EDEM3 have been identiﬁed subse-
quently by a data base search and their involvement in ERAD
has been already assessed [46,48,49]. Based on the UniGene
expression proﬁle, the three proteins are frequently expressed
in the same organs but with some diﬀerence. For example,
EDEM2 is present alone in the adrenal gland and EDEM1
in the parathyroid. EDEM3 diﬀers from EDEM1 and EDEM2
for the presence of a protease-associated domain of unknown
function and for the presence of the ER retention signal
KDEL (Fig. 3). It is not yet clear if the role of the EDEM pro-
teins is redundant in the cell. Alignment of EDEM1, EDEM2,
EDEM3 with the other ER- and Golgi-resident members of
the GH47 family reveals conservation of about 440 residues,
the so-called mannosidase homology domain amongst family
members (Fig. 3). There is little or no conservation beyond this
domain [48,49]. More importantly (see below) EDEM proteins
conserve all catalytic residues required for glycolytic activity
and structural modelling indicates no diﬀerence in their spatial
location [30]. The topology of EDEM1 is controversial as it
has been initially described as a type-II ER transmembrane
protein in COS cells [47], with the uncleaved signal sequence
as transmembrane region associating with the membrane-re-
gion of Cnx to form a functional complex [50]. However, spe-
ciﬁc algorithms (e.g. Signal P [49]) predict eﬃcient cleavage ofthe EDEM1 signal peptide, with low probability (less than 1%)
to serve as a membrane-anchor. Consistently, more recently
analysis showed that EDEM1 is a luminal protein in
HEK293 cells [49]. These contrasting results might be ex-
plained by variations in signal peptide cleavage in diﬀerent cell
lines. EDEM2 and EDEM3 are soluble proteins of the ER
[46,48,49].
The intralumenal level of EDEM1, EDEM2 and EDEM3 is
adapted to variations of ER cargo load (e.g. upon diﬀerentia-
tion of B cells in antibody-secreting plasma cells) or in re-
sponse to accumulation of misfolded polypeptides in the ER
lumen. These conditions activate a transcriptional program
regulated by the ER stress-sensor Ire1 and the Ire1-dependent
transcription factor Xbp1. Ire1 is a multifunctional transmem-
brane protein characterized by a kinase and an endoribonuc-
lease domain in its cytoplasmic C-terminal portion. In
response to ER stress, Ire1 dimerizes [51] and undergoes auto-
phosphorylation that activates the endoribonucleolytic func-
tion. Activated Ire1 performs an unconventional splicing
leading to intron removal from the mRNA coding for Xbp1,
an UPR-speciﬁc b-ZIP transcription factor [52]. Intron re-
moval results in a frame shift that leads to synthesis of a more
stable gene product acting as a more potent transcription
factor [52]. The spliced Xbp1 product binds to speciﬁc ER
stress-responsive cis-acting elements thereby activating the
transcription of select genes involved, as an example, in ERAD
[53]. EDEM1, EDEM2 and EDEM3 are amongst the gene
products induced upon activation of the Ire1/Xbp1 stress-
response pathway [49,53].
Overexpression of recombinant EDEM1 [47,50,54], EDEM2
[48,49] and EDEM3 [46], thus conditions that mimics acute
ER stress, accelerates release of terminally misfolded glyco-
proteins from the Cnx chaperone system [50,54] thereby
accelerating their elimination from the ER lumen. On the
other hand, reduction of the endogenous EDEM1 level
obtained by RNA interference [54,55] or inactivation of the
Ire1/Xbp1 pathway that would induce EDEM proteins expres-
sion upon ER stress decrease eﬃciency of glycoprotein’s
ERAD and eventually compromise the cell’s secretory capacity
[53,56].3.4. How do EDEM proteins assist glycoprotein degradation
from the ER?
Despite conservation of the mannosidase domain, the
S. cerevisiae ortholog of EDEM1 is enzymatically inactive
[33,57] and has been proposed to act as a lectin that binds fold-
ing-defective proteins carrying N-linked glycans from which
the mannose B has been removed [33]. How ERAD substrates
are then delivered to the site of retro-translocation into the
cytosol for proteasomal degradation remains unclear. A role
for the Yos9p as a bridging protein between the machinery
that extracts terminally misfolded proteins from the folding
environment and the machinery that retro-translocates them
across the ER membrane has been suggested [34,58,59]. Yos9p
binds, in fact, misfolded glycoproteins through a lectin domain
similar to the mannose-binding domain of members of the
mannose-6-P receptor family and has been shown to be asso-
ciated to the Hrd1p retro-translocation complex [60].
Again, in mammalian cells the machinery is more complex
and not completely conserved mechanistically. Firstly, a func-
tional ortholog of Yos9p has not yet been identiﬁed. Secondly,
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substrates to the translocation site can be hypothesized based
on data showing that EDEM1 associates with derlin2 and der-
lin3, two putative components of a membrane channel for pro-
tein export from the mammalian ER [61]. Moreover, bacterial
toxins exploit the ERAD machinery to deliver their active sub-
units in the host cell cytosol. EDEM1 has been shown to par-
ticipate in the retro-translocation of the active subunit of the
ricin toxin [62]. Thirdly, an enzymatic activity for EDEM
proteins has been postulated based on data showing faster
de-mannosylation of folding-defective polypeptides upon ele-
vation of the intralumenal level of EDEM1 [44] and EDEM3
[46]. Enhanced de-mannosylation upon overexpression is abol-
ished by a glutamic acid to glutamine mutation (E220Q in
EDEM1 and E147Q [44] in EDEM3 [46]) corresponding to
the E333Q mutation that inactivates the glycanase activity of
the ER a1,2 mannosidase I [45]. These data would be consis-
tent with EDEMs being enzymatically active ER proteins even
though, formally, it can still not be excluded that enhanced de-
mannosylation relies on recruitment of an active mannosidase
upon substrates association with the EDEM proteins. So far,
no data has been generated in vitro showing that puriﬁed
EDEMs can remove mannose residues from oligosaccharides.
Of interest is that the study by Olivari et al. shows that en-
hanced substrate de-mannosylation upon EDEM1 overexpres-
sion also occur in the B3F7 cell line, where the only removable
mannose residues are those on the N-glycan’s branch A (see
above and Fig. 1C) [44].
As it has also been shown that EDEM1 inhibits aggregation
of misfolded glycoproteins released from Cnx, independent of
its putative enzymatic activity [44,63], emerging models postu-
late that EDEM proteins facilitate ERAD of glycoproteins by
interrupting futile folding-attempts in the Cnx chaperone sys-
tem. This results from enhanced removal of mannose residues,
including the re-glucosylatable mannose A. The lectin chaper-
one activity of EDEMs also prevents entry of folding-defective
proteins in oﬀ pathways characterized by formation of cova-
lent aggregates that would delay protein disposal from the
ER [64]. EDEM’s association with translocon components
would actually also promote substrate extrusion from the
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